Calendario›LKFT›GLPG1972 film-coated tablets
GLPG1972 film-coated tablets
A Study in Healthy Male Volunteers to Test How the Test Medicine GLPG1972 is Taken up by the Body When Given by Mouth and Into the Vein as an Injection
Ensayo de Lakefront Biotherapeutics NV en Voluntarios sanos.
- Fase
- Fase 1
- Estado
- Completado
- Participantes
- 6
- Centros
- 1
- Fin del objetivo primario
- oct 2019
previstos
fecha real
Qué significa cada fase y cada estado.
Estudio de intervención, no aleatorizado, abierto. Comenzó en sep 2019.
Qué mide
Change of total radioactivity excreted in urine and feces combined (Period 2) (From Day 1 pre-dose up to Day 10) (del registro, en inglés)
Cómo lo describe el promotor
En el documentoEn inglés, del registroThe sponsor wants to investigate in this study how well the test medicine is taken up by the body when given orally (by mouth) as a tablet and solution, and as a solution for infusion (into a vein). The oral solution and solution for infusion will be radiolabelled. 'Radiolabelled' means that the test medicine has a radioactive component which helps us to track where the test medicine is in the body, what it is broken down into, and how it leaves the body. The sponsor will also look at the safety and tolerability of the test medicine.
Más ensayos de LKFT
| Ensayo | Fase | Estado | Lectura de resultados |
|---|---|---|---|
| OM336 | Fase 1 | Reclutando pacientes | dic 2026 (prevista) |
| OM336 | Fase 1 | Reclutando pacientes | jun 2027 (prevista) |
| Long-Term Follow-Up Study of Gamgertamig | no aplica | Aún sin reclutar | dic 2029 (prevista) |
| GLPG CAR T-cell therapy · Hesperia | Fase 3 | Reclutando pacientes | jul 2039 (prevista) |
| GLPG5101 · Atalanta-1 | Fase 1/2 | Interrumpido | may 2026 (real) |
| GLPG3667 · GALARISSO | Fase 2 | Completado | oct 2025 (real) |
Todos los de LKFT, en su ficha.
Ficha completa en ClinicalTrials.gov (NCT04136327), actualizada en nov 2019.